This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
robotics: Archive
Serve Robotics Prioritizes Efficiency Over Expansion: Will it Pay Off?
by Harendra Ray
SERV is prioritizing fleet efficiency and recurring revenue growth as it works to strengthen the long-term autonomous delivery business.
SERVPositive Net Change UBERNegative Net Change DASHNegative Net Change
robotics
ABM Industries (ABM) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ABMNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Can ONDS Turn Its Australian Defense Win Into a Bigger Global Pipeline?
by Zacks Equity Research
ONDS lands a $6.9M Australian defense order for portable counter-drone kits, expanding its allied defense presence after the DZYNE acquisition.
ONDSPositive Net Change RTXNegative Net Change DPROPositive Net Change
aerospace communications robotics tech-stocks
Buy Tesla Stock Before Q2 Earnings, or Wait for the Results?
by Shaun Pruitt
Tesla (TSLA) is set to report Q2 results after the closing bell on Wednesday, July 22, with investors hoping the EV leader can build on a surprisingly strong delivery report.
TSLAPositive Net Change
artificial-intelligence auto-tires-trucks autonomous-vehicles earnings electric-vehicles investing large-cap magnificent-7 robotics self-driving-cars
Should You Buy Crown Holdings (CCK) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
CCKPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Tesla's Earnings Setup: Most of the Good News Is Already Out
by Bryan Hayes
The delivery rebound appears real and a Q2 earnings beat looks likely.
TSLAPositive Net Change
artificial-intelligence auto-tires-trucks autonomous-vehicles earnings electric-vehicles energy investing robotics self-driving-cars
AI Data Growth is Exploding: Can Western Digital Keep Up?
by Zacks Equity Research
WDC sees AI-driven data growth fueling long-term HDD demand as new storage technologies and its focused strategy target hyperscale opportunities.
WDCPositive Net Change STXPositive Net Change SNDKPositive Net Change
artificial-intelligence business-services cloud-computing computers robotics tech-stocks
Should You Buy the Dip in Drone Stocks and ETFs?
by Neena Mishra
We examine the investment case for drone stocks and highlight two ETFs.
NOCNegative Net Change AVAVPositive Net Change KTOSPositive Net Change UMACPositive Net Change JEDIPositive Net Change DRNZPositive Net Change
aerospace agriculture automation autonomous-vehicles etfs robotics
Newsmax (NMAX) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
NMAXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Top China Tech Plays Worth Adding to Your Portfolio in 2H26
by Vasundhara Sawalka
NetEase and peers gain appeal as U.S.-China trade easing and policy shifts lift confidence in Chinese tech into 2H26.
NTESNegative Net Change TSMPositive Net Change GDSPositive Net Change KCPositive Net Change
artificial-intelligence china cloud-computing electric-vehicles medical-devices robotics semiconductor tech-stocks thematic